Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: How should we conciliate these new findings with the Zephyr trial results?

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)2009-2010
Number of pages2
JournalCritical care medicine
Issue number8
StatePublished - Aug 2011


  • Linezolid
  • pneumonia
  • vancomycin

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this